Coupling magnetic levitation of graphene oxide –protein complexes with blood levels of glucose for early detection of pancreatic adenocarcinoma
ConclusionIf confirmed by further studies on larger cohorts, a multiplexed Maglev-based nanotechnology-enabled blood test could be employed as a screening tool for PDAC in populations with hyperglycemia.
Source: Cancer Nanotechnology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Cholesterol | Diabetes | Endocrinology | Laboratory Medicine | Nanotechnology | Pancreas | Pancreatic Cancer | Statistics | Study